How Long Does a Temporary Knee Spacer Last?

A temporary knee spacer is designed to stay in place for roughly six to twelve weeks, though real-world retention times vary far more than that neat window suggests. The spacer is implanted after an infected knee replacement is removed and serves two jobs: delivering a high local dose of antibiotics directly to the infected site and holding the joint space open so surrounding tissues don’t contract. In one early-experience study, the median spacer retention was about sixteen weeks, with some patients keeping theirs for over two years when clinical circumstances prevented a timely second surgery.¹ What determines the actual duration has less to do with the spacer itself and more to do with whether the infection clears, how the patient’s bone and soft tissue hold up, and whether reimplantation surgery is medically feasible.

Why the Spacer Exists in the First Place

When a knee replacement becomes deeply infected, the most common strategy is a two-stage revision. In the first stage, surgeons remove the infected prosthesis and all contaminated cement, then implant a temporary spacer made of antibiotic-loaded bone cement. The patient also receives intravenous antibiotics, typically for four to six weeks.² Once blood tests and joint fluid samples suggest the infection has been eradicated, the second stage occurs: the spacer comes out and a new prosthesis goes in. The minimum gap between stages is generally at least six weeks, though many surgeons wait longer to be confident the infection is truly gone.³

The spacer’s antibiotic function and its mechanical function are both time-limited by design. It is not built to last decades the way a knee replacement is. The cement slowly releases antibiotics into the surrounding tissue at concentrations far higher than what you could safely deliver through a vein, targeting bacteria right at the source. Meanwhile, the physical presence of the spacer prevents the gap left by the removed prosthesis from collapsing under the pull of muscles and scar tissue.

How Long the Antibiotics Actually Work

The antibiotic release from a cement spacer follows a predictable pattern: a large initial burst in the first one to two days, then a gradual decline. Research indicates that antibiotic concentrations remain above the levels needed to kill most common infecting bacteria for about six to twelve weeks.⁴ This is part of why the conventional inter-stage interval clusters around that same timeframe. After those first weeks, the spacer still contains antibiotic, but it leaches out at concentrations that may no longer be reliably therapeutic.

The exact concentrations depend heavily on which antibiotics are mixed into the cement and how much is used. Vancomycin and gentamicin are among the most common choices, and studies measuring local fluid around spacers have found initial concentrations that are orders of magnitude above what’s needed, sometimes exceeding 400 micrograms per milliliter on day one before tapering over subsequent weeks.⁵ There is ongoing work to extend the release window. One approach threads absorbable sutures through the cement, creating channels that let antibiotics escape more efficiently as the suture material degrades; in lab testing, this roughly doubled the elution beyond the first day over a seven-week period.⁶

The practical takeaway is that once you pass the three-month mark, the spacer is mostly serving as a mechanical placeholder rather than a drug-delivery device. It’s still useful in that role, but the urgency to move to second-stage surgery shifts from “let the antibiotics finish working” to “don’t leave a non-permanent device bearing loads indefinitely.”

Static Versus Articulating Spacers

Knee spacers come in two broad designs. A static spacer is a solid block of antibiotic cement that fills the joint space but does not allow movement. An articulating spacer is shaped more like a simplified knee prosthesis and permits some bending and straightening. A third, newer variant uses a metal-on-polyethylene bearing surface that mimics an actual knee replacement even more closely.

Articulating spacers consistently produce better range of motion and function scores. In one study with at least five years of follow-up, patients with articulating spacers achieved an average of 111 degrees of knee flexion after their final revision, compared with 82 degrees for those who had static spacers. Physical function scores were also significantly higher in the articulating group.⁷ Static spacers, meanwhile, were associated with more adverse events, including cement dislodgement and bone erosion from the rigid block sitting against weakened bone.⁸ That said, failure rates at two years did not differ significantly between the types, suggesting that the choice affects quality of life during the spacer period more than it affects infection control.

For the question of how long a spacer lasts, the design matters because articulating spacers tend to be more tolerable for longer stays. Patients can walk with limited weight-bearing, and the surrounding muscles and ligaments maintain some tone. Static spacers, by immobilizing the knee, tend to cause more soft tissue contracture and bone loss over time, making a longer wait between stages more problematic.

Mechanical Complications and the Limits of Cement

Cement spacers were never engineered for long-term load-bearing, and the data on mechanical failure reflect that. In a study of over 150 knee spacers, about one in five developed a mechanical complication: cement dislodgement, spacer dislocation, or hardware failure. These complications forced earlier-than-planned reimplantation in roughly a third of the affected cases.⁹ Knee spacers had triple the mechanical complication rate of hip spacers, likely because the knee joint transmits forces differently and the spacer sits under greater shear stress.

The risk of fracture through the spacer itself is real, particularly with extended use. A case report documented a transverse fracture through the femoral component of an articulating spacer after prolonged implantation, visible on both X-rays and MRI.¹⁰ Biomechanical testing has shown that when a spacer shifts into a dislocated position, its ability to resist breaking drops by roughly seventeen-fold compared with normal alignment.¹¹ In practical terms, a spacer that migrates even slightly out of position becomes dramatically more vulnerable to catastrophic breakage.

Static spacers bring their own mechanical headaches. Because they don’t allow motion, forces concentrate at the cement-bone interface, leading to migration, dislodgement of cement fragments, and erosion of the underlying bone stock. Loss of bone makes the eventual second-stage surgery harder, sometimes requiring larger or more constrained prostheses, bone grafts, or even custom implants.¹²

What Happens When Spacers Stay In Much Longer

Some patients end up keeping their spacers far beyond the planned interval. The reasons vary: persistent infection that hasn’t cleared, medical conditions that make a second surgery too risky, or a patient’s personal decision to defer another operation. In those cases, the spacer effectively becomes a semi-permanent implant by default rather than by design.

The outcomes for long-term retained spacers are mixed. One study tracked patients who kept prosthetic-style articulating spacers for an average of about 44 months. Of eighteen patients, fifteen maintained well-functioning spacers without needing revision. Functional scores were surprisingly good, with knee scores in the low 90s. Three patients eventually needed revision: one for reinfection and two for mechanical loosening at roughly four to six years.¹³ A more recent study found that patients who retained well-balanced metal-on-polyethylene spacers had low infection recurrence, no catastrophic failures, and patient-reported outcomes comparable to those who went through the full two-stage revision.¹⁴

But those relatively encouraging findings come with caveats. In a different cohort of patients who retained conventional cement spacers long-term, signs of mechanical wear or failure showed up on imaging in the vast majority. The cumulative incidence of all-cause spacer revision reached about one in five at two years for knee spacers, with supracondylar femur fractures and spacer dislocations as the most common serious complications.¹⁵ And prolonged antibiotic suppression therapy did not reliably prevent reinfection in patients retaining spacers long-term. The presence of a draining wound was strongly associated with new infections, often caused by entirely different bacteria than the original culprit.¹⁶

Living with a Spacer

The period between stages is not easy. With an articulating spacer, patients can typically walk with a walker or crutches, but the knee doesn’t work anything like a normal joint or even a standard knee replacement. Gait analysis of patients with preformed articulating spacers found that walking speed dropped by about 70 percent compared with healthy controls, and the operated knee’s range of motion during walking was reduced by roughly 60 percent.¹⁷ The body compensates by shifting loads to the other leg and adjusting posture, which keeps people mobile but puts extra stress on the opposite knee and the lower back.

Weight-bearing is typically restricted. Traditional guidance has been touch-down weight-bearing only, but biomechanical testing suggests dynamic spacers can handle substantially more load than previously assumed, potentially allowing more active rehabilitation during the waiting period.¹⁸ Whether surgeons actually allow this depends on the specific spacer, how stable it looked intraoperatively, and the patient’s bone quality.

When the First Spacer Doesn’t Clear the Infection

Sometimes the initial spacer period fails to eradicate the infection, and the spacer itself has to be exchanged for a new one before the final prosthesis can go in. This is one of the toughest scenarios in joint replacement surgery. In one study, nearly half of patients who needed a spacer exchange ultimately failed treatment, with the majority of those failures occurring within two years.¹⁹ Another analysis found that five-year infection-free survival in patients who required a spacer exchange was about 64 percent, compared with 78 percent in those who went straight from first spacer to final prosthesis without needing an exchange.²⁰

The patients who need spacer exchanges tend to have more comorbidities, more resistant organisms, and a longer total time with a spacer in place. The additional surgery also takes a toll on function: patient-reported physical function scores after final reimplantation were consistently lower in the exchange group.²¹ Each additional operation means more bone loss, more soft-tissue trauma, and a higher cumulative anesthesia risk. This is a significant reason surgeons try to optimize the first spacer interval rather than rushing to reimplant or accepting prolonged spacer retention as a default strategy.

Reinfection Rates After the Full Two-Stage Process

Even when everything goes according to plan, reinfection after two-stage revision is not rare. One study using conventional spacers reported reinfection in about one in four patients, though that cohort included particularly complex cases.²² A large review of two-stage revisions using articulating preformed spacers reported better figures, with infection eradication in most patients over follow-up ranging from two to thirteen years.²³ The overall average success rate for infection eradication with two-stage knee revision has been estimated at around 90 percent across pooled studies, though the number varies with organism virulence, patient health, and surgical technique.²⁴

Fungal infections deserve a special mention because they often require longer spacer retention and more aggressive antifungal therapy. In a small series of fungal periprosthetic infections treated with staged revision, no recurrences were seen at a mean follow-up of about three and a half years, but the treatment protocols were considerably more demanding than for routine bacterial infections.²⁵

The Emerging One-Stage Alternative

A natural question for anyone facing a spacer period is whether the whole two-stage process is necessary. One-stage exchange, where the infected prosthesis is removed and a new one implanted in a single surgery, eliminates the spacer entirely. Historically, two-stage revision has been considered the gold standard, but a prospective randomized trial published in 2025 challenged that hierarchy. At two years, the one-stage approach achieved a 97 percent success rate compared with 91 percent for two-stage revision, with roughly three times the odds of overall success even after adjusting for resistant organisms and patient health factors.²⁶

That trial is significant because it is one of the first to randomize patients rather than relying on surgeon preference, which has historically biased one-stage results toward easier cases. Not every patient is a candidate for one-stage exchange. Those with severe bone loss, unidentified organisms, or poor soft-tissue envelopes may still need the staged approach. But the finding puts real pressure on the assumption that every infected knee replacement needs a spacer period, and it is likely to shift practice over the coming years.

Cost and Access Considerations

Two-stage revision is expensive. An analysis comparing molded all-cement spacers with metal-on-polyethylene spacers found total treatment costs of roughly $24,000 to $25,000 across both stages, with the spacer itself accounting for about 17 percent of that total.²⁷ The indirect costs are harder to quantify but arguably larger: weeks to months of restricted mobility, lost work, caregiver burden, and the physical and psychological toll of living with a temporary joint.

In lower-resource settings, prefabricated commercial spacers may be prohibitively expensive, and hand-molded spacers made intraoperatively from generic bone cement remain the norm. These can be shaped using silicone molds to approximate the fit of commercial products. The tradeoff is that the antibiotic dose in hand-molded spacers can be customized to the specific infection, while commercial spacers come with a fixed formulation that may not be ideal for every pathogen.²⁸ Biomechanical studies suggest hand-molded spacers perform comparably to commercial ones in terms of load tolerance, which matters for allowing any meaningful weight-bearing during the interim period.

Practical Factors That Extend or Shorten the Timeline

Several real-world variables push the spacer interval beyond the textbook window or, less commonly, allow it to be shortened:

Persistent infection markers: If blood inflammatory markers stay elevated or joint fluid cultures come back positive, reimplantation gets postponed. There’s no safe shortcut here.
Resistant organisms: Methicillin-resistant bacteria and fungal infections often require longer antibiotic courses, which delays the second surgery.
Patient health: Uncontrolled diabetes, immunosuppression, poor nutrition, and cardiovascular disease can all delay wound healing and increase surgical risk, making surgeons more cautious about scheduling the second stage.
Bone and soft-tissue condition: If the first surgery revealed severe bone loss or tissue damage, the surgical team may need time to plan for augmented reconstruction, which adds weeks or months.
Surgical scheduling: In health systems with long wait times, the spacer period can stretch simply because the operating room isn’t available.

In the study mentioned earlier, the average spacer retention time was about 26 weeks, but the range was enormous: eight weeks at the shortest to over two years at the longest.¹ That wide spread reflects the reality that “temporary” is a relative term when it comes to knee spacers. The device is temporary in intent, but the body, the bacteria, and the healthcare system all get a vote in how long it actually stays.